PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodline Partners LP | 733,735 | $4,593,181 | 0.05% |
| PDT Partners, LLC | 49,713 | $311,203 | 0.04% |
| XTX Topco Ltd | 27,225 | $170,429 | 0.03% |
| HARBOURVEST PARTNERS LLC | 11,533 | $72,197 | 0.02% |
| ArrowMark Colorado Holdings LLC | 270,426 | $1,692,867 | 0.02% |
| Alkeon Capital Management | 1,479,867 | $9,263,968 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 95,000 | $594,700 | 0.01% |
| FEDERATED HERMES, INC. | 840,816 | $5,263,508 | 0.01% |
| Baker Brothers Advisors | 322,024 | $2,015,870 | 0.01% |
| Vontobel Holding Ltd. | 332,250 | $2,079,885 | 0.01% |
| FISHMAN JAY A LTD/MI | 30,000 | $187,800 | 0.01% |
| Assenagon Asset Management S.A. | 420,824 | $2,634,358 | 0.01% |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 86,401 | $540,870 | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 163,962 | $1,026,402 | 0.01% |
| PRINCIPAL FINANCIAL GROUP INC | 926,735 | $5,801,364 | 0.00% |
| MARTINGALE ASSET MANAGEMENT L P | 21,296 | $133,313 | 0.00% |
| JPMORGAN CHASE & CO | 4,075,504 | $25,512,656 | 0.00% |
| Citadel Advisors | 2,126,821 | $13,313,900 | 0.00% |
| HRT FINANCIAL LP | 48,323 | $302 | 0.00% |
| Quantbot Technologies LP | 6,666 | $41,729 | 0.00% |
External links
This page lists PMV PHARMACEUTICALS INC's shareholders in Q2 2023. To view PMV PHARMACEUTICALS INC's shareholder history, click here.